Objective-To evaluate treatment of group A ( haemolytic streptococcal pharyngitis with amoxycillin once daily compared with phenoxymethylpenicillin three or four times a day. Design-Randomised controlled study of consecutive patients presenting with symptoms suggestive of group A ( haemolytic streptococcal pharyngitis in whom culture of a throat swab yielded positive results.
Introduction
In general practice about a quarter of patients present with infections of the upper respiratory tract yet there is great variation in the management of these common disorders,' 2 among which streptococcal pharyngitis is one of the commonest.
For almost 40 years penicillin has been considered the antibiotic of choice for the treatment of group A (3 haemolytic streptococcal pharyngitis. Over the years numerous clinical studies have compared benzathine or oral penicillin with other new antibiotics.34 Claims have been made that some of these agents, most recently cephalosporins, are more convenient because they can be taken once a day and may result in fewer bacteriological failures of treatment than penicillin. ' Only a few studies have tried to assess compliance as it relates to frequency of administration.67 A regimen of orally administered antibiotics for streptococcal pharyngitis given once rather than several times each day would be convenient, especially for children attending school, for single parent families, and for those families in which both parents work, and may result in improved patient compliance.
Two studies have evaluated once daily oral penicillin (buffered benzylpenicillin and phenoxymethylpenicillin) and showed conflicting results. 89 We evaluated once daily amoxycillin, a semisynthetic penicillin with a longer half life than those penicillins used in the previous two studies and cheaper than orally administered cephalosporin. Outcome was measured by the ability to isolate group A ( haemolytic streptocodtcus from the pharynx 24 hours after treatment was started, the impact on clinical course, and the rate of bacteriological failure of treatment.
Subjects and methods
The study took place in five family medicine practices over six months. Consecutive patients with clinical findings suggestive of group A (3 haemolytic streptococcal pharyngitis were enrolled in the study after informed consent had been obtained. All patients were older than 3 years and were considered to require immediate treatment with antibiotics.
Patients with a history of hypersensitivity to penicillin or who had received antibiotics within the previous 72 hours, had a chronic disease, or had a personal or family history of rheumatic fever were excluded. The presence of fever, follicular exudate, enlarged lymph nodes, sore throat, dysphagia, headache, and gastrointestinal symptoms was recorded at the first visit, and afterwards patients were followed up daily by telephone until all symptoms cleared. A throat culture was obtained from each patient by vigorously swabbing the posterior pharynx and tonsils. The swab was sent in transport medium to the regional microbiology laboratory and streaked on to blood agar plate (Hy-Lab, Rehovot, Israel). The plate was then examined for the presence of (3 haemolytic streptococci; a bacitracin disc (Rosco, Denmark) was placed on a subculture and incubated overnight at 37°C. (3 Haemolytic streptococci that were sensitive to bacitracin were presumptively identified as group A.
At the initial visit patients were randomly assigned to receive phenoxymethylpenicillin 250 mg three or four times daily or amoxycillin once daily (children 50 mg/kg and adults 750 mg for 10 days; fig 1) . All patients were asked to return in 24-48 hours for a follow up visit and a repeat throat swab. Antibiotics were discontinued in patients whose first throat culture yielded negative results, and they were not evaluated further. Others were followed up with a daily telephone call until all symptoms cleared. Patients returned for an additional throat culture 14- fig 1) . Table I shows the 2 depicts, as an example, the course of fever, headache, malaise, and sore throat. Table II shows the results of throat cultures over time. No difference was found between the two groups after 48 hours and none was noted in the days lost from school or work (fig 3) .
A significantly better rate of bacteriological eradication on day 14 was observed in the amoxycillin group. There were no rashes or other important side effects with either antibiotic. The concentrations of antistreptolysin 0 and antideoxyribonuclease B were not measured nor was M and T typing of the throat culture isolates performed.
Discussion
The importance of adequate treatment of group A ,B haemolytic streptococcal pharyngitis continued to be emphasised in medical reports as a result of recent articles documenting the continued risk of subsequent rheumatic fever."-" The diagnostic and prescribing habits of general practitioners from 17 European countries for acute tonsillitis were recently assessed. given a single dose of 800 000 units of buffered benzylpenicillin potassium each day for 10 days. Forty two per cent of the patients had throat cultures that yielded positive results on follow up in the two months after completion ofthe study compared with 14-15% in the children of the control group. Given the fact that serotyping was not performed, bacteriological failure could not be distinguished from newly acquired disease. The authors' conclusion was that buffered benzylpenicillin was inadequate for the once daily oral treatment of streptococcal pharyngitis.8
In 1986, 196 patients with streptococcal pharyngitis were treated with once daily cefadroxial and their responses compared with those of controls receiving phenoxymethylpenicillin three times a day. A single daily dose of cefadroxil seemed to be as effective as phenoxymethylpenicillin given three times daily. The rate of bacteriological failure was only 2% in the cefadroxial group.' In 1989, 154 patients were randomly assigned to receive phenoxymethylpenicillin once daily or three times daily for 10 days. The two regimens were comparable in their ability to eradicate the streptococcus from the upper respiratory tract in 18-24 hours and in their impact on the clinical course of the disease. The rate of bacteriological failure, however, was significantly higher in the patients taking only a single daily dose.9
Cefadroxil (an oral cephalosporin) was found to be effective when given once daily, but it is much more expensive than penicillin. The two studies which used oral penicillin showed unsatisfactory results. Amoxycillin is an oral penicillin with an excellent absorption from the gastrointestinal tract and a longer half life (30 minutes) than other oral penicillins and is considerably cheaper than the oral cephalosporins."'56 There is no difference in cost between daily treatment with phenoxymethylpenicillin or amoxycillin. '7 Amoxycillin is already regularly used for prophylaxis of endocarditis in patients with abnormal heart valves who undergo dental extraction and other procedures. It is also used to treat urinary tract infections, and in both cases a single high dose or short course is recommended.
We have shown that amoxycillin once daily (the equivalent daily dose) for 10 
